US 11123360
Oligonucleotides to treat eye disease
granted A61KA61K31/7125A61K9/0048
Quick answer
US patent 11123360 (Oligonucleotides to treat eye disease) held by ProQR Therapeutics II B.V. expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ProQR Therapeutics II B.V.
- Grant date
- Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/7125, A61K9/0048, A61P, A61P27/02